HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients.

Abstract
Quantitative polymerase chain reaction (PCR) with patient-specific, allele-specific oligonucleotide (ASO) primers for individual immunoglobulin H VDJ region (ASO-PCR) amplification was performed using several sources of clinical material, including mRNA from peripheral blood cells (PBMNCs), whole bone marrow cells (BMMNCs), and the CD20+ CD38- B-cell population in bone marrow, as well as cell-free DNA from the sera of patients with multiple myeloma (MM). We designed the ASO primers and produced sufficient PCR fragments to evaluate tumor burden in 20 of 30 bone marrow samples at diagnosis. Polymerase chain reaction amplification efficiency depended on primer sequences because the production of ASO-PCR fragments did not correlate with serum M-protein levels. However, the ASO-PCR levels in BMMNCs showed statistically significant correlations with those in PBMNCs and CD20+ CD38- B-cells. The good association between the BMMNC and PBMNC data indicated that PBMNCs could be a suitable source for monitoring minimal residual disease (MRD). In the case of cell-free DNA, ASO-PCR levels showed a unique pattern and remained high even after treatment. Because the sequence information for each ASO-PCR product was identical to the original, the cell-free DNA might also be useful for evaluating MRD. Moreover, the ASO-PCR products were clearly detected in 17 of 22 mRNA samples from CD20+ CD38- populations, suggesting that MM clones might exist in relatively earlier stages of B cells than in plasma cells. Thus, ASO-PCR analysis using various clinical materials is useful for detecting MRD in MM patients as well as for clarifying MM pathogenesis.
AuthorsHiroshi Sata, Hirohiko Shibayama, Ikuhiro Maeda, Yoko Habuchi, Eiji Nakatani, Kentaro Fukushima, Jiro Fujita, Sachiko Ezoe, Seiji Tadokoro, Tetsuo Maeda, Masao Mizuki, Satoru Kosugi, Masashi Nakagawa, Shuji Ueda, Masato Iida, Yukihiro Tokumine, Yasuhiko Azenishi, Hideki Mitsui, Kenji Oritani, Yuzuru Kanakura
JournalExperimental hematology (Exp Hematol) Vol. 43 Issue 5 Pg. 374-381.e2 (May 2015) ISSN: 1873-2399 [Electronic] Netherlands
PMID25591497 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antigens, CD20
  • DNA Primers
  • Immunoglobulin Heavy Chains
  • Oligonucleotides
  • ADP-ribosyl Cyclase 1
Topics
  • ADP-ribosyl Cyclase 1 (metabolism)
  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Antigens, CD20 (metabolism)
  • B-Lymphocytes (metabolism)
  • Bone Marrow Cells (metabolism)
  • DNA Primers (genetics)
  • Female
  • Humans
  • Immunoglobulin Heavy Chains (genetics)
  • Leukocytes, Mononuclear (metabolism)
  • Male
  • Middle Aged
  • Multiple Myeloma (genetics, pathology)
  • Neoplasm, Residual (genetics)
  • Oligonucleotides (genetics)
  • Polymerase Chain Reaction (methods)
  • Reproducibility of Results
  • Tumor Burden (genetics)
  • VDJ Exons (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: